Real-World Characteristics of Patients with Severe Asthma prior to Starting Dupilumab: The ProVENT Study

CONCLUSIONS: This analysis suggests that patients eligible for dupilumab treatment display various clinical and biochemical characteristics rather than one clear-cut …